Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 296-117-1 | CAS number: 92257-28-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity:
Data available for the structurally and functionally similar read across chemicals has been reviewed to determine the acute oral toxicity of the test chemical 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8). The studies are as mentioned below:
1. Acute oral toxicity study was conducted using test chemical in groups of 5 Carworth-Wistar male rats at the concentration range of 1880-3230 mg/kg bw. The test chemical was dissolved in suitable vehicle and administered via oral route. The dosages are arranged in a logarithmic series differing by a factor of two. Based upon mortalities during a 14-day observation period, the most probable LD50 value and its fiducial range are estimated by the method of Thompson using the Tables of Weil. The figures in parentheses show limits of ±1.96 standard deviations while the absence of parentheses indicates that no range is calculable because no dosage resulted in fractional mortality. 50% Mortality observed at 2410 mg/kg bw. Therefore, LD50 was considered to be 2410 mg/kg bw, wih 95% confidence limit of 1880-3230 mg/kg bw, when Carworth-Wistar male rats were treated with test chemical via oral route.
2. Acute oral toxicity study was conducted using test chemical in rats at the concentration of 2000 mg/kg bw. No Mortality observed at 2000 mg/kg bw. Therefore, LD50 was considered to be >2000 mg/kg bw, when rats were treated with test chemical via oral route.
Thus, based on the above summarised studies, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) and it’s structurally similar read across substances, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) cannot be classified for acute oral toxicity. Hence, based on the data available for the structurally similar read across chemical, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs is not likely to be toxic in the dose range of >2000 – 2410 mg/Kg bw.
Acute Inhalation toxicity:
2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) has very low vapour pressure (1.49E-10 Pa), so the potential for the generation of inhalable vapours is very low. Also the normal conditions of use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalatory route will be highly unlikely and therefore this end point was considered for waiver.
Acute Dermal Toxicity:
Data available for the structurally and functionally similar read across chemicals has been reviewed to determine the acute dermal toxicity of the test chemical 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8). The studies are as mentioned below:
1. The acute dermal toxicity study was designed and conducted for test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. It was concluded that the acute dermal median lethal dose (LD50) of test chemical, when administered to male and female Sprague Dawley rats was found to be >2000 mg/kg body weight. Thus, according to CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not classify as an acute dermal toxicant. CLP Classification: “Not classified”.
2. Acute Dermal toxicity study was conducted using test chemical in groups of 4 albino New Zealand male rabbits at the concentration range of 2700-18500 mg/kg bw. The fur is removed from the entire trunk by clipping, and the dose is retained beneath an impervious plastic film. Dosages greater than 20 ml/kg cannot be retained in contact with the skin. The animals are immobilized during the 24-hour contact period, after which the film is removed and the rabbits are caged for the subsequent 14-day observation period. The LD50 is calculated as described by a technique closely akin to the one-day cuff method of Draize and associates. 50% Mortality observed at 7100 mg/kg bw. Therefore, LD50 was considered to be 7100 mg/kg bw, wih 95% confidence limit of 2700-18500 mg/kg bw, when groups of 4 albino New Zealand male rabbits were treated with test chemical by dermal application occlusively.
Thus, based on the above summarised studies, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) and it’s structurally similar read across substances, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) cannot be classified for acute dermal toxicity. Hence, based on the data available for the structurally similar read across chemical, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs is not likely to be toxic in the dose range of >2000 – 7100 mg/Kg bw for acute dermal toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- experimental data of read across substances
- Justification for type of information:
- Data for the target chemical is summarized based on the structurally similar read across chemicals
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- WoE report is based on 2 acute oral toxicity studies as- WoE-2 and WoE-3.
Acute Oral toxicity test was carried out to study the effects of the test chemicals on rodents. - GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material : 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs.
- IUPAC name : N-(2-ethylhexyl)-1-[4-(2-phenyldiazen-1-yl)phenyl]naphthalen-2-amine
- Molecular formula : C30H33N3
- Molecular weight : 435.60 g/mol
- Substance type : Organic
- Physical state : Liquid - Species:
- rat
- Strain:
- other: 1. Carworth-Wistar rats 2. not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- 1. TEST ANIMALS
- Age at study initiation: 4-5 weeks
- Weight at study initiation: 90-120 grams
- Fasting period before study: Fasting was not done.
- Diet (e.g. ad libitum): Rockland rat diet
2. not specified - Route of administration:
- other: 1. oral: gavage 2. oral: unspecified
- Vehicle:
- other: 1. Vehicle was used 2. unchanged (no vehicle)
- Details on oral exposure:
- 1. not specified
2. not specified - Doses:
- 1. 2410 mg/kg (Range of 1880-3230 mg/kg bw)
2. 2000 mg/kg - No. of animals per sex per dose:
- 1. groups of 5
2. not specified - Control animals:
- not specified
- Details on study design:
- 1. not specified
2. not specified - Statistics:
- 1. Based upon mortalities during a 14-day observation period, the most probable LD50 value and its fiducial range are estimated by the method of Thompson using the Tables of Weil. The figures in parentheses show limits of ±1.96 standard deviations while the absence of parentheses indicates that no range is calculable because no dosage resulted in fractional mortality.
2. not specified - Preliminary study:
- 1. not specified
2. not specified - Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 410 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 880 - 3 230
- Remarks on result:
- other: 50% Mortality observed
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No Mortality observed
- Mortality:
- 1. 50% Mortality observed at 2410 mg/kg bw
2. No Mortality observed at 2000 mg/kg bw - Clinical signs:
- 1. not specified
2. not specified - Body weight:
- 1. not specified
2. not specified - Gross pathology:
- 1. not specified
2. not specified - Other findings:
- 1. not specified
2. not specified - Interpretation of results:
- other: Not classified
- Conclusions:
- The test chemcial 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) is not likely to be toxic atleast in the dose range of >2000 - 2410 mg/Kg bw.
- Executive summary:
Data available for the structurally and functionally similar read across chemicals has been reviewed to determine the acute oral toxicity of the test chemical 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8). The studies are as mentioned below:
1. Acute oral toxicity study was conducted using test chemical in groups of 5 Carworth-Wistar male rats at the concentration range of 1880-3230 mg/kg bw. The test chemical was dissolved in suitable vehicle and administered via oral route. The dosages are arranged in a logarithmic series differing by a factor of two. Based upon mortalities during a 14-day observation period, the most probable LD50 value and its fiducial range are estimated by the method of Thompson using the Tables of Weil. The figures in parentheses show limits of ±1.96 standard deviations while the absence of parentheses indicates that no range is calculable because no dosage resulted in fractional mortality. 50% Mortality observed at 2410 mg/kg bw. Therefore, LD50 was considered to be 2410 mg/kg bw, wih 95% confidence limit of 1880-3230 mg/kg bw, when Carworth-Wistar male rats were treated with test chemical via oral route.
2. Acute oral toxicity study was conducted using test chemical in rats at the concentration of 2000 mg/kg bw. No Mortality observed at 2000 mg/kg bw. Therefore, LD50 was considered to be >2000 mg/kg bw, when rats were treated with test chemical via oral route.
Thus, based on the above summarised studies, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) and it’s structurally similar read across substances, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) cannot be classified for acute oral toxicity. Hence, based on the data available for the structurally similar read across chemical, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs is not likely to be toxic in the dose range of >2000 – 2410 mg/Kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 410 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from publication.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Quality of whole database:
- Waiver
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- experimental data of read across substances
- Justification for type of information:
- Data for the target chemical is summarized based on the structurally similar read across chemicals
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- WoE report is based on 2 acute dermal toxicity studies as- WoE-2 and WoE-3.
Acute Dermal toxicity test was carried out to study the effects of the test chemicals on rodents. - GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material : 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs.
- IUPAC name : N-(2-ethylhexyl)-1-[4-(2-phenyldiazen-1-yl)phenyl]naphthalen-2-amine
- Molecular formula : C30H33N3
- Molecular weight : 435.60 g/mol
- Substance type : Organic
- Physical state : Liquid - Species:
- other: 1. rat 2. rabbit
- Strain:
- other: 1. Sprague-Dawley 2. albino New Zealand rabbits
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 1. TEST ANIMALS
- Source: National Institute of Biosciences, Pune.
- Females nulliparous and non-pregnant: No data available
- Age at study initiation: Young adult male and female rats aged between 8 – 12 weeks were used.
- Weight at study initiation: The weight range of approximately 216.9 to 251.9 grams at initiation of dosing.
Body weights at the start : Male Mean: 241.18 g (= 100 %); Minimum : 235.8 g (- 2.23 %); Maximum : 251.9 g (+ 4.44 %)
Female Mean: 221.08 g (= 100 %); Minimum : 216.9 g (- 1.89 %); Maximum : 228.5 g (+ 3.36 %)
- Identification: Each rat was individually identified by the cage number.
- Housing: The rats were individually housed in polycarbonate cages with paddy husk as bedding.
- Diet (e.g. ad libitum): Rodent feed supplied by the Nutrivet Life Sciences, Pune, was provided ad libitum from individual feeders.
- Water (e.g. ad libitum): Water was provided ad libitum from individual bottles attached to the cages. All water was from a local source and passed through the reverse osmosis membrane before use.
- Acclimation period: 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.7 to 21.8 degree centigrade.
- Humidity (%): 56.2% to 60.1%
- Air changes (per hr): Ten to fifteen air changes per hour.
- Photoperiod (hrs dark / hrs light): An artificial light and dark cycle of 12 hours each was provided to the room.
IN-LIFE DATES: 11-07-2017 to 26-07-2017
2. TEST ANIMALS
- Weight at study initiation: 2.5 to 3.5 kg - Type of coverage:
- other: 1. semiocclusive 2. occlusive
- Vehicle:
- other: 1. unchanged (no vehicle) 2. not specified
- Details on dermal exposure:
- 1. TEST SITE
- Area of exposure: Trunk (dorsal surface and sides from scapular to pelvic area)
- % coverage: Approximately 10% of the body surface area.
- Type of wrap if used: Porous gauze dressing and non-irritating tape.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): Distilled water was used to remove residual test item.
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg/kg bw
2. TEST SITE
- Area of exposure: The fur is removed from the entire trunk by clipping
- Type of wrap if used: impervious plastic film
REMOVAL OF TEST SUBSTANCE
- Washing (if done): the film is removed
- Time after start of exposure:24-hour - Duration of exposure:
- 1. 24 hours
2. 24-hour - Doses:
- 1. 2000 mg/kg
2. 7100 mg/kg (Range of 2700-18500 mg/kg bw) - No. of animals per sex per dose:
- 1. 10 (5/sex)
2. groups of 4 - Control animals:
- other: 1. not specified 2. not specified
- Details on study design:
- 1. - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Twice daily
- Necropsy of survivors performed: Yes
- Other examinations performed: Clinical Observations and General Appearance: Animals were observed for clinical signs, mortality, until sacrifice. Onset, duration and severity of any sign were recorded. The clinical signs and mortality observations were conducted at 10, 30, 60 minutes, 2, 4 and 6 hours on the day of dosing and once daily thereafter for 14 day. Daily observation was done as far as possible at the same time. The observations were included general clinical signs, observations of eyes, mucous membranes, respiratory, circulatory system and behavior pattern.
Evaluation of Dermal Reaction: Dermal reaction was observed daily for study period of 14 days.
Body weights: Individual animal body weights were recorded pre-test (prior to administration of the test item), day 7 and at termination on day 14.
Gross Pathology: Necropsy was performed on animals surviving at the end of the study. Macroscopic examination of all the orifices, cavities and tissues were made and the findings were recorded. All animals surviving the study period were sacrificed by the carbon dioxide asphyxiation technique (day 15).
Histopathology: No gross abnormalities were observed in animals sacrificed terminally hence, no histopathology was performed.
2. not specified - Statistics:
- 1. No data
2. The LD50 is calculated as described by a technique closely akin to the one-day cuff method of Draize and associates. - Preliminary study:
- 1. No data
2. not specified - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No morality was observed
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 7 100 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 2 700 - 18 500
- Remarks on result:
- other: 50% Mortality observed
- Mortality:
- 1. Sex : Male Group I - All animals survived through the study period of 14 days.
Sex : Female Group I - All animals survived through the study period of 14 days.
2. 50% Mortality observed at 7100 mg/kg bw - Clinical signs:
- 1. Sex : Male Group I - Animal treated at the dose level of 2000 mg/kg body weight did not result in any signs of toxicity during the study period of 14 days.
Sex : Female Group I - Animal treated at the dose level of 2000 mg/kg body weight did not result in any signs of toxicity during the study period of 14 days.
2. not specified - Body weight:
- 1. Sex : Male Group I (2000 mg/kg) - Percent body weight gain after 7 days and 14 days was found to be 9.30% and 18.14% respectively.
Sex : Female Group I (2000 mg/kg) - Percent body weight gain after 7 days and 14 days was found to be 4.60% and 9.06% respectively.
2. not specified - Gross pathology:
- 1. Gross pathological examination did not reveal any abnormalities in animals from 2000 mg/kg dose group.
2. not specified - Other findings:
- 1. - Other observations: Evaluation of Dermal Reaction
Sex : Male Group I - Animal treated at the dose level of 2000 mg/kg body weight did not result in any skin reaction during the study period of 14 days.
Sex : Female Group I - Animal treated at the dose level of 2000 mg/kg body weight did not result in any skin reaction during the study period of 14 days.
2. not specified - Interpretation of results:
- other: Not classified
- Conclusions:
- The test chemcial 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) is not likely to be toxic in the dose range of >2000 - 7100 mg/Kg bw for acute dermal toxicity.
- Executive summary:
Data available for the structurally and functionally similar read across chemicals has been reviewed to determine the acute dermal toxicity of the test chemical 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8). The studies are as mentioned below:
1. The acute dermal toxicity study was designed and conducted for test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. It was concluded that the acute dermal median lethal dose (LD50) of test chemical, when administered to male and female Sprague Dawley rats was found to be >2000 mg/kg body weight. Thus, according to CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not classify as an acute dermal toxicant. CLP Classification: “Not classified”.
2. Acute Dermal toxicity study was conducted using test chemical in groups of 4 albino New Zealand male rabbits at the concentration range of 2700-18500 mg/kg bw. The fur is removed from the entire trunk by clipping, and the dose is retained beneath an impervious plastic film. Dosages greater than 20 ml/kg cannot be retained in contact with the skin. The animals are immobilized during the 24-hour contact period, after which the film is removed and the rabbits are caged for the subsequent 14-day observation period. The LD50 is calculated as described by a technique closely akin to the one-day cuff method of Draize and associates. 50% Mortality observed at 7100 mg/kg bw. Therefore, LD50 was considered to be 7100 mg/kg bw, wih 95% confidence limit of 2700-18500 mg/kg bw, when groups of 4 albino New Zealand male rabbits were treated with test chemical by dermal application occlusively.
Thus, based on the above summarised studies, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) and it’s structurally similar read across substances, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) cannot be classified for acute dermal toxicity. Hence, based on the data available for the structurally similar read across chemical, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs is not likely to be toxic in the dose range of >2000 – 7100 mg/Kg bw for acute dermal toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 7 100 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from publication.
Additional information
Acute oral toxicity:
Data available for the structurally and functionally similar read across chemicals has been reviewed to determine the acute oral toxicity of the test chemical 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8). The studies are as mentioned below:
1. Acute oral toxicity study was conducted using test chemical in groups of 5 Carworth-Wistar male rats at the concentration range of 1880-3230 mg/kg bw. The test chemical was dissolved in suitable vehicle and administered via oral route. The dosages are arranged in a logarithmic series differing by a factor of two. Based upon mortalities during a 14-day observation period, the most probable LD50 value and its fiducial range are estimated by the method of Thompson using the Tables of Weil. The figures in parentheses show limits of ±1.96 standard deviations while the absence of parentheses indicates that no range is calculable because no dosage resulted in fractional mortality. 50% Mortality observed at 2410 mg/kg bw. Therefore, LD50 was considered to be 2410 mg/kg bw, wih 95% confidence limit of 1880-3230 mg/kg bw, when Carworth-Wistar male rats were treated with test chemical via oral route.
2. Acute oral toxicity study was conducted using test chemical in rats at the concentration of 2000 mg/kg bw. No Mortality observed at 2000 mg/kg bw. Therefore, LD50 was considered to be >2000 mg/kg bw, when rats were treated with test chemical via oral route.
Thus, based on the above summarised studies, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) and it’s structurally similar read across substances, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) cannot be classified for acute oral toxicity. Hence, based on the data available for the structurally similar read across chemical, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs is not likely to be toxic in the dose range of >2000 – 2410 mg/Kg bw.
Acute Inhalation toxicity:
2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) has very low vapour pressure (1.49E-10 Pa), so the potential for the generation of inhalable vapours is very low. Also the normal conditions of use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalatory route will be highly unlikely and therefore this end point was considered for waiver.
Acute Dermal Toxicity:
Data available for the structurally and functionally similar read across chemicals has been reviewed to determine the acute dermal toxicity of the test chemical 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8). The studies are as mentioned below:
1. The acute dermal toxicity study was designed and conducted for test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. It was concluded that the acute dermal median lethal dose (LD50) of test chemical, when administered to male and female Sprague Dawley rats was found to be >2000 mg/kg body weight. Thus, according to CLP criteria for acute toxicity rating for the chemicals, it infers that test chemical does not classify as an acute dermal toxicant. CLP Classification: “Not classified”.
2. Acute Dermal toxicity study was conducted using test chemical in groups of 4 albino New Zealand male rabbits at the concentration range of 2700-18500 mg/kg bw. The fur is removed from the entire trunk by clipping, and the dose is retained beneath an impervious plastic film. Dosages greater than 20 ml/kg cannot be retained in contact with the skin. The animals are immobilized during the 24-hour contact period, after which the film is removed and the rabbits are caged for the subsequent 14-day observation period. The LD50 is calculated as described by a technique closely akin to the one-day cuff method of Draize and associates. 50% Mortality observed at 7100 mg/kg bw. Therefore, LD50 was considered to be 7100 mg/kg bw, wih 95% confidence limit of 2700-18500 mg/kg bw, when groups of 4 albino New Zealand male rabbits were treated with test chemical by dermal application occlusively.
Thus, based on the above summarised studies, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) and it’s structurally similar read across substances, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) cannot be classified for acute dermal toxicity. Hence, based on the data available for the structurally similar read across chemical, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs is not likely to be toxic in the dose range of >2000 – 7100 mg/Kg bw for acute dermal toxicity.
Justification for classification or non-classification
Based on the above experimental studies on 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) and it’s structurally similar related read across substances, it can be concluded that LD50 value is >2000 mg/kg bw, for acute oral and dermal toxicity. Thus, comparing this value with the criteria of CLP regulation, 2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo) phenyl]azo]-, ar' and ar''-Me derivs (CAS no.: 92257-28-8) cannot be classified for acute oral and dermal toxicity. For Acute Inhalation toxicity wavier were added so, not possible to classify.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.